When Elon Musk started Neuralink in 2016, he tapped leading neurosurgeon Ben Rapoport to join as a co-founder. But two years later, citing safety and scalability concerns, Rapoport left to co-found a rival company: Precision Neuroscience. Today, we speak with his co-founder, Michael Mager, about what sets Precision apart, the future of brain–computer interfaces (BCIs), and what Precision has already been able to achieve with over 70 implanted patients.  Learn more about your ad choices. Visit podcastchoices.com/adchoices